CME Group (NASDAQ:CME) Price Target Increased to $228.00 by Analysts at Barclays

CME Group (NASDAQ:CME) had its target price upped by Barclays from $226.00 to $228.00 in a report released on Thursday, Benzinga reports. The firm currently has an equal weight rating on the financial services provider’s stock.

A number of other equities research analysts have also issued reports on CME. Rosenblatt Securities reiterated a sell rating and issued a $187.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday. Deutsche Bank Aktiengesellschaft restated a hold rating and set a $210.00 price objective (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Keefe, Bruyette & Woods raised their price objective on CME Group from $222.00 to $226.00 and gave the company a market perform rating in a research report on Thursday. Bank of America raised their price objective on CME Group from $209.00 to $216.00 and gave the company a neutral rating in a research report on Thursday. Finally, Morgan Stanley raised their price objective on CME Group from $222.00 to $225.00 and gave the company an equal weight rating in a research report on Tuesday, April 9th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group presently has a consensus rating of Hold and an average target price of $217.80.

CME Group Trading Down 0.0 %

NASDAQ:CME opened at $212.54 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market capitalization of $76.51 billion, a price-to-earnings ratio of 24.18, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49. CME Group has a one year low of $175.73 and a one year high of $223.80. The business has a fifty day moving average price of $214.76 and a 200-day moving average price of $211.93.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the prior year, the business posted $2.42 EPS. CME Group’s revenue for the quarter was up 3.2% compared to the same quarter last year. Sell-side analysts forecast that CME Group will post 9.58 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were paid a $1.15 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.16%. This is an increase from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Institutional Trading of CME Group

Several institutional investors have recently added to or reduced their stakes in CME. AE Wealth Management LLC lifted its stake in CME Group by 25.5% in the third quarter. AE Wealth Management LLC now owns 2,543 shares of the financial services provider’s stock worth $509,000 after purchasing an additional 516 shares during the last quarter. Private Trust Co. NA lifted its stake in CME Group by 14.9% in the third quarter. Private Trust Co. NA now owns 3,147 shares of the financial services provider’s stock worth $630,000 after purchasing an additional 408 shares during the last quarter. Koshinski Asset Management Inc. purchased a new position in shares of CME Group during the third quarter worth approximately $298,000. CX Institutional increased its position in shares of CME Group by 590.1% during the third quarter. CX Institutional now owns 14,810 shares of the financial services provider’s stock worth $2,965,000 after acquiring an additional 12,664 shares during the period. Finally, Oak Thistle LLC purchased a new position in shares of CME Group during the third quarter worth approximately $462,000. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.